Financhill
Back

Sutro Biopharma, Inc. 10K Form

Sell
21

STRO
Sutro Biopharma, Inc.

Last Price:
$10.00
Seasonality Move:
-18.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive STRO News And Ratings

See the #1 stock for the next 7 days that we like better than STRO

STRO Financial Statistics

Sales & Book Value

Annual Sales: $62M
Cash Flow: $-38.4M
Price / Cash Flow: 0
Annual Sales: $-10.25
Price / Book: 1.64

Profitability

EPS (TTM): -17.75110
Net Income (TTM): $-216.8M
Gross Margin: $54.8M
Return on Equity: -10195.04%
Return on Assets: -66.39%

Sutro Biopharma, Inc. Earnings Forecast

Key Sutro Biopharma, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for STRO is 88.37%.
  • The Selling, General & Administrative Expenses for STRO have been equal to 78.10% of Gross Profit Margin.
  • The Research & Development expenses have been 406.24% of Revenue.
  • The Net Earning history of STRO is -366.62% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Sutro Biopharma, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: STRO
CUSIP: 869367
Website: sutrobio.com

Debt

Debt-to-Equity Ratio: -2.61
Current Ratio: 2.53
Quick Ratio: 2.39

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

STRO Technical Analysis vs Fundamental Analysis

Sell
21
Sutro Biopharma, Inc. (STRO) is a Sell

Is Sutro Biopharma, Inc. a Buy or a Sell?